Cargando…

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands

BACKGROUND: Herpes zoster (HZ) is a painful disease affecting a considerable part of the elderly. Programmatic HZ vaccination of elderly people may considerably reduce HZ morbidity and its related costs, but the extent of these effects is unknown. In this article, the potential effects and cost-effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Lier, Alies, van Hoek, Albert Jan, Opstelten, Wim, Boot, Hein J, de Melker, Hester E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928772/ https://www.ncbi.nlm.nih.gov/pubmed/20707884 http://dx.doi.org/10.1186/1472-6963-10-237

Ejemplares similares

Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster
por: van Lier, Alies, et al.
Publicado: (2015)

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
por: de Boer, Pieter T., et al.
Publicado: (2018)

Hospitalization due to varicella in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2011)

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands
por: Thorrington, Dominic, et al.
Publicado: (2018)

Intention to vaccinate universally against varicella, rotavirus gastroenteritis, meningococcal B disease and seasonal influenza among parents in the Netherlands: an internet survey
por: van Lier, Alies, et al.
Publicado: (2017)

Cost-Effectiveness of Herpes Zoster Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2019)

Negative attitude and low intention to vaccinate universally against varicella among public health professionals and parents in the Netherlands: two internet surveys
por: van Lier, Alies, et al.
Publicado: (2016)

Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011
por: van Lier, Alies, et al.
Publicado: (2016)

Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020
por: Middeldorp, Marit, et al.
Publicado: (2021)

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2019)

Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017)

Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
por: Marra, Yasmin, et al.
Publicado: (2022)

Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
por: Giannelos, Nikolaos, et al.
Publicado: (2023)

Herpes zoster ophthalmicus or Herpes zoster maxillaris?
por: Chandravanshi, Shivcharan Lal, et al.
Publicado: (2009)

Disseminated Herpes Zoster in an Immunocompetent Elderly Patient
por: Yoon, Keon Jung, et al.
Publicado: (2013)

Assessment of vaccine candidates for persons aged 50 and older: a review
por: Eilers, Renske, et al.
Publicado: (2013)

Policy and practice of programmatic management of latent tuberculosis infection in The Netherlands
por: de Vries, Gerard, et al.
Publicado: (2017)

Cost-effectiveness of herpes zoster vaccines in the U.S.: A systematic review
por: Meredith, Neil R., et al.
Publicado: (2022)

On the issue of costs in programmatic assessment
por: van der Vleuten, Cees P. M., et al.
Publicado: (2016)

The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older
por: Lehmann, Birthe A., et al.
Publicado: (2017)

Mumps Vaccine Effectiveness Against Orchitis
por: Hahné, Susan, et al.
Publicado: (2012)

Herpes Zoster
por: Warneros Loyo, María de Lourdes
Publicado: (1995)

Herpes Zoster
Publicado: (1890)

Herpes Zoster
por: Wile, Henry
Publicado: (1886)

Disseminated Cutaneous Herpes Zoster in an Immunocompetent Elderly Patient
por: Gomez, Eric, et al.
Publicado: (2014)

20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
por: Curran, Desmond, et al.
Publicado: (2021)

Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France
por: Blein, Cecile, et al.
Publicado: (2015)

Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus (HZO)
por: Aukes, Laurie, et al.
Publicado: (2017)

Herpes Zoster in Solid Organ Transplantation: Incidence and Risk Factors
por: Kho, Marcia M. L., et al.
Publicado: (2021)

The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands
por: McDonald, Scott A, et al.
Publicado: (2012)

Herpes Zoster Ophthalmicus and Lateral Rectus Palsy in an Elderly Patient
por: Yalcinbayir, Ozgur, et al.
Publicado: (2011)

Zosteriform Lesions in an Elderly Man-Look Beyond Herpes Zoster
por: Raveendra, Leena, et al.
Publicado: (2015)

Herpes Zoster / Revisión Bibliográfica /
por: Escamilla Sánchez, Jacqueline
Publicado: (1993)

Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands
por: de Boer, Pieter T., et al.
Publicado: (2020)

Herpes Zoster Ophthalmicus
por: Catron, Thomas, et al.
Publicado: (2008)

Necrodestructive Herpes Zoster
por: Gupta, Sanjeev, et al.
Publicado: (2012)

Herpes zoster in infancy
por: Gupta, Lalit Kumar, et al.
Publicado: (2013)

Herpes Zoster Vaccination
por: Kim, Kyung Hoon
Publicado: (2013)

Is Herpes Zoster Contagious?
Publicado: (1885)

The Pathology of Herpes Zoster
Publicado: (1908)

Cannot write session to /tmp/vufind_sessions/sess_9dnjv28ocs0gpaor8lg538q8cc